Anti-atherosclerotic effects of sitagliptin in patients with type 2 diabetes mellitus.

CONCLUSION: Sitagliptin shows an adiponectin-dependent anti-atherothrombotic effect, which may be beneficial for primary prevention of atherothrombosis, in patients with type 2 diabetes. PMID: 26251624 [PubMed]

http://www.ncbi.nlm.nih.gov/pubmed/26251624?dopt=Abstract

Source: Diabetes Metab - August 10, 2015 Category: Endocrinology Authors: Omoto S, Taniura T, Nishizawa T, Tamaki T, Shouzu A, Nomura S Tags: Diabetes Metab Syndr Obes Source Type: research

More News: Diabetes | Diabetes Mellitus | Diabetes Type 2 | Endocrinology | Januvia | Statistics | Study